Journal article
Canadian Implantable Defibrillator Study (CIDS)
Abstract
BACKGROUND: Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implantable cardioverter defibrillator (ICD) terminates VT or VF, but it is not known whether this device prolongs life in these patients compared with medical therapy with amiodarone.
METHODS AND RESULTS: A total of 659 patients with resuscitated VF or VT or with unmonitored …
Authors
Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O’Brien B
Journal
Circulation, Vol. 101, No. 11, pp. 1297–1302
Publisher
Wolters Kluwer
Publication Date
March 21, 2000
DOI
10.1161/01.cir.101.11.1297
ISSN
0009-7322